Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia.
D000818:Animals; D002230:Carbidopa / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004338:Drug Combinations; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D006834:Hydrazines / Q000627:therapeutic use*; D007980:Levodopa / Q000627:therapeutic use*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects
D004338:Drug Combinations; D006834:Hydrazines; D011954:Receptors, Dopamine; D007980:Levodopa; D002230:Carbidopa